nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Topoisomerase Inhibitors—Topotecan—cervical cancer	0.606	1	CiPCiCtD
Epirubicin—uterine cancer—cervical cancer	0.186	0.558	CtDrD
Epirubicin—ovarian cancer—cervical cancer	0.148	0.442	CtDrD
Epirubicin—Metastatic neoplasm—Topotecan—cervical cancer	0.00187	0.081	CcSEcCtD
Epirubicin—Acute leukaemia—Topotecan—cervical cancer	0.00126	0.0543	CcSEcCtD
Epirubicin—AURKA—Irinotecan—Topotecan—cervical cancer	0.00114	0.724	CbGdCrCtD
Epirubicin—CHD1—uterine cervix—cervical cancer	0.0011	0.0338	CbGeAlD
Epirubicin—CHD1—decidua—cervical cancer	0.00105	0.0323	CbGeAlD
Epirubicin—CHD1—endometrium—cervical cancer	0.000994	0.0306	CbGeAlD
Epirubicin—CHD1—mammalian vulva—cervical cancer	0.000962	0.0296	CbGeAlD
Epirubicin—CHD1—uterus—cervical cancer	0.000916	0.0282	CbGeAlD
Epirubicin—Bullous eruption—Topotecan—cervical cancer	0.000909	0.0393	CcSEcCtD
Epirubicin—AURKA—uterine cervix—cervical cancer	0.000886	0.0273	CbGeAlD
Epirubicin—AURKA—renal system—cervical cancer	0.000829	0.0255	CbGeAlD
Epirubicin—CHD1—female reproductive system—cervical cancer	0.000824	0.0254	CbGeAlD
Epirubicin—AURKA—endometrium—cervical cancer	0.000801	0.0247	CbGeAlD
Epirubicin—AURKA—mammalian vulva—cervical cancer	0.000775	0.0239	CbGeAlD
Epirubicin—Myelosuppression—Topotecan—cervical cancer	0.000766	0.0331	CcSEcCtD
Epirubicin—CHD1—female gonad—cervical cancer	0.000749	0.0231	CbGeAlD
Epirubicin—CHD1—vagina—cervical cancer	0.000745	0.0229	CbGeAlD
Epirubicin—DHCR7—uterine cervix—cervical cancer	0.000741	0.0228	CbGeAlD
Epirubicin—AURKA—uterus—cervical cancer	0.000739	0.0227	CbGeAlD
Epirubicin—YWHAG—uterine cervix—cervical cancer	0.00068	0.0209	CbGeAlD
Epirubicin—AURKA—female reproductive system—cervical cancer	0.000664	0.0204	CbGeAlD
Epirubicin—Mucosal inflammation—Topotecan—cervical cancer	0.000649	0.0281	CcSEcCtD
Epirubicin—DHCR7—mammalian vulva—cervical cancer	0.000648	0.02	CbGeAlD
Epirubicin—YWHAG—decidua—cervical cancer	0.000648	0.02	CbGeAlD
Epirubicin—YWHAG—renal system—cervical cancer	0.000636	0.0196	CbGeAlD
Epirubicin—YWHAG—endometrium—cervical cancer	0.000615	0.0189	CbGeAlD
Epirubicin—AURKA—female gonad—cervical cancer	0.000604	0.0186	CbGeAlD
Epirubicin—AURKA—vagina—cervical cancer	0.0006	0.0185	CbGeAlD
Epirubicin—Febrile neutropenia—Topotecan—cervical cancer	0.000597	0.0258	CcSEcCtD
Epirubicin—YWHAG—mammalian vulva—cervical cancer	0.000595	0.0183	CbGeAlD
Epirubicin—Pelvic pain—Topotecan—cervical cancer	0.00059	0.0255	CcSEcCtD
Epirubicin—UGT2B7—renal system—cervical cancer	0.000575	0.0177	CbGeAlD
Epirubicin—YWHAG—uterus—cervical cancer	0.000567	0.0175	CbGeAlD
Epirubicin—DHCR7—female reproductive system—cervical cancer	0.000555	0.0171	CbGeAlD
Epirubicin—Neuralgia—Topotecan—cervical cancer	0.000517	0.0224	CcSEcCtD
Epirubicin—YWHAG—female reproductive system—cervical cancer	0.00051	0.0157	CbGeAlD
Epirubicin—Lung disorder—Topotecan—cervical cancer	0.000508	0.0219	CcSEcCtD
Epirubicin—PLA2G4A—uterine cervix—cervical cancer	0.000507	0.0156	CbGeAlD
Epirubicin—DHCR7—female gonad—cervical cancer	0.000505	0.0156	CbGeAlD
Epirubicin—DHCR7—vagina—cervical cancer	0.000502	0.0155	CbGeAlD
Epirubicin—PLA2G4A—decidua—cervical cancer	0.000483	0.0149	CbGeAlD
Epirubicin—TOP2A—uterine cervix—cervical cancer	0.000482	0.0148	CbGeAlD
Epirubicin—CHD1—lymph node—cervical cancer	0.000482	0.0148	CbGeAlD
Epirubicin—PLA2G4A—renal system—cervical cancer	0.000475	0.0146	CbGeAlD
Epirubicin—Rash erythematous—Topotecan—cervical cancer	0.000469	0.0203	CcSEcCtD
Epirubicin—Pleural effusion—Topotecan—cervical cancer	0.000469	0.0203	CcSEcCtD
Epirubicin—YWHAG—female gonad—cervical cancer	0.000464	0.0143	CbGeAlD
Epirubicin—YWHAG—vagina—cervical cancer	0.000461	0.0142	CbGeAlD
Epirubicin—UGT2B7—female reproductive system—cervical cancer	0.00046	0.0142	CbGeAlD
Epirubicin—TOP2A—decidua—cervical cancer	0.000459	0.0141	CbGeAlD
Epirubicin—PLA2G4A—endometrium—cervical cancer	0.000459	0.0141	CbGeAlD
Epirubicin—PLA2G4A—mammalian vulva—cervical cancer	0.000444	0.0137	CbGeAlD
Epirubicin—Rigors—Topotecan—cervical cancer	0.00044	0.019	CcSEcCtD
Epirubicin—TOP2A—Irinotecan—Topotecan—cervical cancer	0.000436	0.276	CbGdCrCtD
Epirubicin—TOP2A—endometrium—cervical cancer	0.000436	0.0134	CbGeAlD
Epirubicin—TOP2A—mammalian vulva—cervical cancer	0.000422	0.013	CbGeAlD
Epirubicin—Extravasation—Topotecan—cervical cancer	0.000412	0.0178	CcSEcCtD
Epirubicin—TOP2A—uterus—cervical cancer	0.000402	0.0124	CbGeAlD
Epirubicin—Hyperbilirubinaemia—Topotecan—cervical cancer	0.000395	0.0171	CcSEcCtD
Epirubicin—AURKA—lymph node—cervical cancer	0.000388	0.012	CbGeAlD
Epirubicin—PLA2G4A—female reproductive system—cervical cancer	0.00038	0.0117	CbGeAlD
Epirubicin—Blood bilirubin increased—Topotecan—cervical cancer	0.00038	0.0164	CcSEcCtD
Epirubicin—Bone pain—Topotecan—cervical cancer	0.000375	0.0162	CcSEcCtD
Epirubicin—Pulmonary embolism—Topotecan—cervical cancer	0.000359	0.0155	CcSEcCtD
Epirubicin—PLA2G4A—female gonad—cervical cancer	0.000346	0.0107	CbGeAlD
Epirubicin—Colitis—Topotecan—cervical cancer	0.000345	0.0149	CcSEcCtD
Epirubicin—PLA2G4A—vagina—cervical cancer	0.000344	0.0106	CbGeAlD
Epirubicin—Neuropathy—Topotecan—cervical cancer	0.000337	0.0146	CcSEcCtD
Epirubicin—TOP2A—female gonad—cervical cancer	0.000329	0.0101	CbGeAlD
Epirubicin—TOP2A—vagina—cervical cancer	0.000327	0.0101	CbGeAlD
Epirubicin—Rash maculo-papular—Topotecan—cervical cancer	0.000326	0.0141	CcSEcCtD
Epirubicin—DHCR7—lymph node—cervical cancer	0.000325	0.01	CbGeAlD
Epirubicin—Neoplasm—Topotecan—cervical cancer	0.000325	0.014	CcSEcCtD
Epirubicin—Sepsis—Topotecan—cervical cancer	0.000312	0.0135	CcSEcCtD
Epirubicin—YWHAG—lymph node—cervical cancer	0.000298	0.00918	CbGeAlD
Epirubicin—ABCC1—uterine cervix—cervical cancer	0.00029	0.00894	CbGeAlD
Epirubicin—ABCC1—decidua—cervical cancer	0.000276	0.00851	CbGeAlD
Epirubicin—Dermatitis bullous—Topotecan—cervical cancer	0.000273	0.0118	CcSEcCtD
Epirubicin—Anaphylactoid reaction—Topotecan—cervical cancer	0.000269	0.0116	CcSEcCtD
Epirubicin—Lethargy—Topotecan—cervical cancer	0.000266	0.0115	CcSEcCtD
Epirubicin—ABCC1—endometrium—cervical cancer	0.000262	0.00808	CbGeAlD
Epirubicin—ABCC1—mammalian vulva—cervical cancer	0.000254	0.00782	CbGeAlD
Epirubicin—Cardiac arrest—Topotecan—cervical cancer	0.000248	0.0107	CcSEcCtD
Epirubicin—ABCC1—uterus—cervical cancer	0.000242	0.00745	CbGeAlD
Epirubicin—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.000235	0.0102	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00023	0.00994	CcSEcCtD
Epirubicin—PLA2G4A—lymph node—cervical cancer	0.000222	0.00685	CbGeAlD
Epirubicin—Pancytopenia—Topotecan—cervical cancer	0.000214	0.00925	CcSEcCtD
Epirubicin—TOP2A—lymph node—cervical cancer	0.000211	0.0065	CbGeAlD
Epirubicin—Neutropenia—Topotecan—cervical cancer	0.000211	0.00911	CcSEcCtD
Epirubicin—Weight increased—Topotecan—cervical cancer	0.000205	0.00887	CcSEcCtD
Epirubicin—YWHAG—mTOR signaling pathway—YY1—cervical cancer	0.000203	0.0718	CbGpPWpGaD
Epirubicin—Pneumonia—Topotecan—cervical cancer	0.000202	0.00874	CcSEcCtD
Epirubicin—Infestation NOS—Topotecan—cervical cancer	0.000201	0.00869	CcSEcCtD
Epirubicin—Infestation—Topotecan—cervical cancer	0.000201	0.00869	CcSEcCtD
Epirubicin—ABCC1—female gonad—cervical cancer	0.000198	0.00609	CbGeAlD
Epirubicin—Neuropathy peripheral—Topotecan—cervical cancer	0.000197	0.00852	CcSEcCtD
Epirubicin—ABCC1—vagina—cervical cancer	0.000197	0.00606	CbGeAlD
Epirubicin—Stomatitis—Topotecan—cervical cancer	0.000196	0.00847	CcSEcCtD
Epirubicin—Sweating—Topotecan—cervical cancer	0.000193	0.00833	CcSEcCtD
Epirubicin—Hepatobiliary disease—Topotecan—cervical cancer	0.00019	0.00822	CcSEcCtD
Epirubicin—Epistaxis—Topotecan—cervical cancer	0.00019	0.00819	CcSEcCtD
Epirubicin—Haemoglobin—Topotecan—cervical cancer	0.000181	0.00784	CcSEcCtD
Epirubicin—Rhinitis—Topotecan—cervical cancer	0.000181	0.00782	CcSEcCtD
Epirubicin—Haemorrhage—Topotecan—cervical cancer	0.00018	0.0078	CcSEcCtD
Epirubicin—Hypoaesthesia—Topotecan—cervical cancer	0.000179	0.00776	CcSEcCtD
Epirubicin—Pharyngitis—Topotecan—cervical cancer	0.000179	0.00774	CcSEcCtD
Epirubicin—Angiopathy—Topotecan—cervical cancer	0.000164	0.00708	CcSEcCtD
Epirubicin—Immune system disorder—Topotecan—cervical cancer	0.000163	0.00704	CcSEcCtD
Epirubicin—Mediastinal disorder—Topotecan—cervical cancer	0.000163	0.00703	CcSEcCtD
Epirubicin—Chills—Topotecan—cervical cancer	0.000162	0.007	CcSEcCtD
Epirubicin—Alopecia—Topotecan—cervical cancer	0.000159	0.00689	CcSEcCtD
Epirubicin—Malnutrition—Topotecan—cervical cancer	0.000157	0.00679	CcSEcCtD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—PIAS3—cervical cancer	0.000156	0.0551	CbGpPWpGaD
Epirubicin—Back pain—Topotecan—cervical cancer	0.000152	0.00657	CcSEcCtD
Epirubicin—Muscle spasms—Topotecan—cervical cancer	0.000151	0.00653	CcSEcCtD
Epirubicin—Ill-defined disorder—Topotecan—cervical cancer	0.000146	0.0063	CcSEcCtD
Epirubicin—Anaemia—Topotecan—cervical cancer	0.000145	0.00628	CcSEcCtD
Epirubicin—Malaise—Topotecan—cervical cancer	0.000142	0.00612	CcSEcCtD
Epirubicin—Leukopenia—Topotecan—cervical cancer	0.000141	0.00608	CcSEcCtD
Epirubicin—Cough—Topotecan—cervical cancer	0.000137	0.00592	CcSEcCtD
Epirubicin—Chest pain—Topotecan—cervical cancer	0.000134	0.00578	CcSEcCtD
Epirubicin—Myalgia—Topotecan—cervical cancer	0.000134	0.00578	CcSEcCtD
Epirubicin—Arthralgia—Topotecan—cervical cancer	0.000134	0.00578	CcSEcCtD
Epirubicin—AURKA—Gastric Cancer Network 1—NOTCH1—cervical cancer	0.000133	0.047	CbGpPWpGaD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000133	0.00574	CcSEcCtD
Epirubicin—Discomfort—Topotecan—cervical cancer	0.000132	0.00571	CcSEcCtD
Epirubicin—Anaphylactic shock—Topotecan—cervical cancer	0.000128	0.00554	CcSEcCtD
Epirubicin—Infection—Topotecan—cervical cancer	0.000127	0.0055	CcSEcCtD
Epirubicin—ABCC1—lymph node—cervical cancer	0.000127	0.00392	CbGeAlD
Epirubicin—Nervous system disorder—Topotecan—cervical cancer	0.000126	0.00543	CcSEcCtD
Epirubicin—Thrombocytopenia—Topotecan—cervical cancer	0.000125	0.00543	CcSEcCtD
Epirubicin—Skin disorder—Topotecan—cervical cancer	0.000124	0.00538	CcSEcCtD
Epirubicin—Hyperhidrosis—Topotecan—cervical cancer	0.000124	0.00536	CcSEcCtD
Epirubicin—Anorexia—Topotecan—cervical cancer	0.000122	0.00528	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000117	0.00505	CcSEcCtD
Epirubicin—Paraesthesia—Topotecan—cervical cancer	0.000115	0.00498	CcSEcCtD
Epirubicin—Dyspnoea—Topotecan—cervical cancer	0.000114	0.00494	CcSEcCtD
Epirubicin—Dyspepsia—Topotecan—cervical cancer	0.000113	0.00488	CcSEcCtD
Epirubicin—Decreased appetite—Topotecan—cervical cancer	0.000111	0.00482	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Topotecan—cervical cancer	0.000111	0.00478	CcSEcCtD
Epirubicin—Fatigue—Topotecan—cervical cancer	0.00011	0.00478	CcSEcCtD
Epirubicin—Pain—Topotecan—cervical cancer	0.00011	0.00474	CcSEcCtD
Epirubicin—Constipation—Topotecan—cervical cancer	0.00011	0.00474	CcSEcCtD
Epirubicin—Feeling abnormal—Topotecan—cervical cancer	0.000106	0.00457	CcSEcCtD
Epirubicin—Gastrointestinal pain—Topotecan—cervical cancer	0.000105	0.00453	CcSEcCtD
Epirubicin—Urticaria—Topotecan—cervical cancer	0.000102	0.0044	CcSEcCtD
Epirubicin—Abdominal pain—Topotecan—cervical cancer	0.000101	0.00438	CcSEcCtD
Epirubicin—Body temperature increased—Topotecan—cervical cancer	0.000101	0.00438	CcSEcCtD
Epirubicin—Hypersensitivity—Topotecan—cervical cancer	9.44e-05	0.00408	CcSEcCtD
Epirubicin—Asthenia—Topotecan—cervical cancer	9.2e-05	0.00398	CcSEcCtD
Epirubicin—Pruritus—Topotecan—cervical cancer	9.07e-05	0.00392	CcSEcCtD
Epirubicin—Diarrhoea—Topotecan—cervical cancer	8.77e-05	0.00379	CcSEcCtD
Epirubicin—Dizziness—Topotecan—cervical cancer	8.47e-05	0.00366	CcSEcCtD
Epirubicin—Vomiting—Topotecan—cervical cancer	8.15e-05	0.00352	CcSEcCtD
Epirubicin—Rash—Topotecan—cervical cancer	8.08e-05	0.00349	CcSEcCtD
Epirubicin—Dermatitis—Topotecan—cervical cancer	8.07e-05	0.00349	CcSEcCtD
Epirubicin—Headache—Topotecan—cervical cancer	8.03e-05	0.00347	CcSEcCtD
Epirubicin—Nausea—Topotecan—cervical cancer	7.61e-05	0.00329	CcSEcCtD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—CASP8—cervical cancer	7.39e-05	0.0261	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—GP6—cervical cancer	7.06e-05	0.025	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 1—NOTCH1—cervical cancer	7.05e-05	0.0249	CbGpPWpGaD
Epirubicin—YWHAG—Class I PI3K signaling events mediated by Akt—MTOR—cervical cancer	6.49e-05	0.023	CbGpPWpGaD
Epirubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—cervical cancer	6.34e-05	0.0224	CbGpPWpGaD
Epirubicin—AURKA—Integrin-linked kinase signaling—CTNNB1—cervical cancer	6.21e-05	0.022	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—GP5—cervical cancer	6.17e-05	0.0218	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—CASP3—cervical cancer	5.59e-05	0.0198	CbGpPWpGaD
Epirubicin—AURKA—Aurora A signaling—TP53—cervical cancer	5.57e-05	0.0197	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—MTOR—cervical cancer	5.51e-05	0.0195	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	5.19e-05	0.0184	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—TP53—cervical cancer	5.01e-05	0.0177	CbGpPWpGaD
Epirubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—cervical cancer	4.79e-05	0.0169	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—UBE3A—cervical cancer	4.48e-05	0.0158	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—CTNNB1—cervical cancer	4.44e-05	0.0157	CbGpPWpGaD
Epirubicin—YWHAG—FoxO family signaling—CTNNB1—cervical cancer	4.4e-05	0.0156	CbGpPWpGaD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—cervical cancer	4.22e-05	0.0149	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—MTOR—cervical cancer	3.91e-05	0.0138	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	3.8e-05	0.0134	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	3.73e-05	0.0132	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GP6—cervical cancer	3.64e-05	0.0129	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SERPIND1—cervical cancer	3.64e-05	0.0129	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—cervical cancer	3.59e-05	0.0127	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—EGFR—cervical cancer	3.52e-05	0.0124	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—HES1—cervical cancer	3.47e-05	0.0123	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	3.3e-05	0.0116	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—cervical cancer	3.25e-05	0.0115	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CASP8—cervical cancer	3.23e-05	0.0114	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GP5—cervical cancer	3.18e-05	0.0112	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	2.97e-05	0.0105	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—cervical cancer	2.95e-05	0.0104	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—CASP8—cervical cancer	2.88e-05	0.0102	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—STAT3—cervical cancer	2.79e-05	0.00986	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—MTOR—cervical cancer	2.7e-05	0.00953	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MTOR—cervical cancer	2.66e-05	0.00941	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	2.52e-05	0.00889	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CASP3—cervical cancer	2.45e-05	0.00865	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—CASP8—cervical cancer	2.4e-05	0.00849	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	2.36e-05	0.00834	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	2.36e-05	0.00833	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	2.32e-05	0.0082	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—CASP3—cervical cancer	2.18e-05	0.0077	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CA9—cervical cancer	2.13e-05	0.00753	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—STAT3—cervical cancer	2.08e-05	0.00737	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	1.94e-05	0.00687	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—EGFR—cervical cancer	1.89e-05	0.0067	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—cervical cancer	1.87e-05	0.00661	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—STAT3—cervical cancer	1.83e-05	0.00647	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—CASP3—cervical cancer	1.82e-05	0.00642	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—cervical cancer	1.81e-05	0.00641	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CASP3—cervical cancer	1.81e-05	0.00639	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	1.77e-05	0.00625	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—CTNNB1—cervical cancer	1.75e-05	0.00619	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	1.74e-05	0.00616	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—EGFR—cervical cancer	1.66e-05	0.00588	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—cervical cancer	1.63e-05	0.00575	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—cervical cancer	1.57e-05	0.00555	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TERT—cervical cancer	1.48e-05	0.00523	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.42e-05	0.00502	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TAAR6—cervical cancer	1.38e-05	0.00489	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	1.29e-05	0.00457	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.23e-05	0.00435	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—cervical cancer	1.16e-05	0.00412	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TERT—cervical cancer	1.12e-05	0.00396	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—STAT3—cervical cancer	1.1e-05	0.00388	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—WNT2—cervical cancer	1.08e-05	0.00382	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.07e-05	0.0038	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.04e-05	0.00366	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKAP13—cervical cancer	9.48e-06	0.00335	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	9.31e-06	0.00329	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	8.98e-06	0.00317	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—MTHFR—cervical cancer	8.64e-06	0.00305	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	8.21e-06	0.0029	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—WNT5A—cervical cancer	8.19e-06	0.00289	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TAAR6—cervical cancer	8.17e-06	0.00289	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TERT—cervical cancer	7.84e-06	0.00277	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CA9—cervical cancer	7.35e-06	0.0026	CbGpPWpGaD
Epirubicin—ABCC1—Disease—WNT2—cervical cancer	7.28e-06	0.00257	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CA9—cervical cancer	7.21e-06	0.00255	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	7.11e-06	0.00251	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	6.89e-06	0.00244	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—cervical cancer	6.62e-06	0.00234	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—WNT2—cervical cancer	6.38e-06	0.00226	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	5.97e-06	0.00211	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CA9—cervical cancer	5.76e-06	0.00204	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—cervical cancer	5.63e-06	0.00199	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKAP13—cervical cancer	5.6e-06	0.00198	CbGpPWpGaD
Epirubicin—ABCC1—Disease—WNT5A—cervical cancer	5.52e-06	0.00195	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—WNT5A—cervical cancer	4.84e-06	0.00171	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—cervical cancer	4.27e-06	0.00151	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH2—cervical cancer	3.39e-06	0.0012	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HES1—cervical cancer	3.18e-06	0.00112	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—cervical cancer	2.98e-06	0.00105	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—cervical cancer	2.98e-06	0.00105	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—cervical cancer	2.92e-06	0.00103	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—cervical cancer	2.79e-06	0.000986	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HES1—cervical cancer	2.78e-06	0.000984	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TERT—cervical cancer	2.78e-06	0.000984	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—cervical cancer	2.74e-06	0.000968	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGFR3—cervical cancer	2.55e-06	0.000903	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TERT—cervical cancer	2.44e-06	0.000862	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOTCH1—cervical cancer	2.4e-06	0.000847	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—cervical cancer	2.34e-06	0.000826	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGFR3—cervical cancer	2.24e-06	0.000791	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOTCH1—cervical cancer	2.1e-06	0.000743	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—cervical cancer	1.87e-06	0.000662	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTOR—cervical cancer	1.8e-06	0.000635	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—cervical cancer	1.79e-06	0.000634	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CTNNB1—cervical cancer	1.59e-06	0.000563	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MTOR—cervical cancer	1.57e-06	0.000557	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—cervical cancer	1.45e-06	0.000512	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CTNNB1—cervical cancer	1.4e-06	0.000493	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—cervical cancer	1.39e-06	0.000491	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—cervical cancer	1.26e-06	0.000446	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—cervical cancer	1.22e-06	0.00043	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—cervical cancer	1.11e-06	0.000391	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—cervical cancer	9.28e-07	0.000328	CbGpPWpGaD
